scispace - formally typeset
J

Jessica Zucman-Rossi

Researcher at University of Paris

Publications -  352
Citations -  39001

Jessica Zucman-Rossi is an academic researcher from University of Paris. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatocellular adenoma. The author has an hindex of 77, co-authored 322 publications receiving 32178 citations. Previous affiliations of Jessica Zucman-Rossi include Council on Education for Public Health & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov, +84 more
- 22 Aug 2013 - 
TL;DR: It is shown that hypermutation localized to small genomic regions, ‘kataegis’, is found in many cancer types, and this results reveal the diversity of mutational processes underlying the development of cancer.
Journal ArticleDOI

International network of cancer genome projects

Thomas J. Hudson, +273 more
TL;DR: Systematic studies of more than 25,000 cancer genomes will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.

Hepatocellular carcinoma.

TL;DR: In this paper, the authors used non-invasive criteria to diagnose hepatocellular carcinoma (HCC) and showed that 25% of all HCCs present potentially actionable mutations, which are yet to translate into clinical practice.
Journal ArticleDOI

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

TL;DR: Functional analyses showed tumor suppressor properties for IRF2, whose inactivation, exclusively found in hepatitis B virus-related tumors, led to impaired TP53 function, and association of mutations in specific genes suggested that Wnt/β-catenin signaling might cooperate in liver carcinogenesis with both oxidative stress metabolism and Ras/mitogen-activated protein kinase (MAPK) pathways.